NeurologyLive Brain Games – July 20, 2025
Table of Contents
Multiple Sclerosis (MS) is a chronic, unpredictable disease of the central nervous system that affects the brain and spinal cord. While there’s no cure,a range of disease-modifying therapies (DMTs) can help manage its course. This week, we’re diving into some key aspects of MS management, testing your knowledge with a swift quiz and offering expert insights.
Understanding disease-Modifying Therapies in Primary progressive MS
Primary Progressive Multiple Sclerosis (PPMS) is a less common form of MS characterized by a steady worsening of neurological function from the onset of symptoms, with no distinct relapses or remissions. Historically, treatment options for PPMS were limited, but advancements have brought new hope.
Question 1: Wich of the following disease-modifying therapies is FDA approved for use in primary progressive MS?
[Placeholder for answer options]
Expert Insight: The landscape of MS treatment is constantly evolving.For PPMS,the FDA has approved specific therapies that have demonstrated efficacy in slowing disease progression. It’s crucial for individuals with PPMS to discuss these options with their neurologist to determine the most suitable treatment plan.
Imaging Correlates of Disability Progression in MS
Magnetic Resonance Imaging (MRI) plays a vital role in diagnosing MS and monitoring disease activity. Beyond identifying new lesions, certain imaging findings can provide valuable clues about long-term disability progression.Question 2: In progressive MS, what imaging finding correlates best with long-term disability progression?
[Placeholder for answer options]
Expert Insight: While new T2 lesions and gadolinium-enhancing lesions are vital indicators of active inflammation in relapsing forms of MS, in progressive MS, the focus often shifts to other MRI markers. Brain atrophy, notably in specific regions, and the accumulation of T1 hypointense lesions (frequently enough referred to as “black holes”) are increasingly recognized as key indicators of neurodegeneration and long-term disability. Understanding these imaging correlates helps clinicians and researchers better predict and manage the long-term course of the disease.
How did You Do?
We hope this quiz sparked some thought and reinforced your understanding of MS management. Share your results and compare with your peers!
How many questions did you get correct?
* [Placeholder for poll]
Remember,staying informed and engaged with your healthcare team is paramount in managing MS effectively.